Medical Devices Investors & VC Firms in Europe

650 firms in this list, with a median first check of $540K. 165 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
IN InHealth Ventures IBBELBRB5 people · Leads rounds	88🔒	London	GB	Pre-Seed–Series A	$500K – $3M	+ Add to CRM
RO Rosetta Capital Ltd. JHKMMFDL8 people	88🔒	Oxford	GB	Growth–Late Stage	—	+ Add to CRM
SY SyndicateRoom TBMGMGAP5 people · Follows rounds	88🔒	Cambridge	GB	Pre-Seed–Series A	—	+ Add to CRM
CR Criteria Bio Ventures PCACSCSC7 people · Leads rounds	88🔒	Barcelona	ES	Seed–Series B	—	+ Add to CRM
QU Qubit Health Capital JNPRDDDM10 people	88🔒	London	GB	—	—	+ Add to CRM
SE Sentica Partners Oy JWMUPTRL10 people	88🔒	Helsinki	FI	Growth	$1.1M – $10.8M	+ Add to CRM
EM Empirical Ventures DBBMDJHT5 people	88🔒	London	GB	Pre-Seed–Seed	—	+ Add to CRM
VE Vespucci Partners ARDBLZJS5 people	88🔒	Budapest	HU	Seed–Series A	$648K – $4.9M	+ Add to CRM
GR Granatus Ventures MHPHYSLD4 people · Leads rounds	88🔒	Yerevan	AM	Seed	—	+ Add to CRM
SI Simpact Ventures JOKGWMKP6 people · Leads rounds	88🔒	Warszawa	PL	Pre-Seed–Series A	$500K – $2M	+ Add to CRM
VE Vesalius Biocapital Partners APCSGMGG6 people · Leads rounds	88🔒	Luxembourg	LU	Seed–Growth	$11M	+ Add to CRM
AV Avonmore Developments MBSB2 people · Leads rounds	88🔒	London	GB	Pre-Seed–Seed	$63K – $315K	+ Add to CRM
LI Linden Capital ABBC2 people	88🔒	Chicago	DE	Pre-Seed–Series A	—	+ Add to CRM
FU Future Positive Capital SHATESPR4 people · Follows rounds	88🔒	—	FR	Pre-Seed–Series A	—	+ Add to CRM
MO Montis Capital ŁDTPMGWS4 people	88🔒	Warsaw	PL	Series A–Growth	$1.6M – $5.5M	+ Add to CRM
TA Target Partners BVDTJWMK7 people	88🔒	Munich	DE	Seed–Late Stage	$1.1M – $3.2M	+ Add to CRM
ST Startup Funding Club JZRSSG3 people	88🔒	—	GB	Pre-Seed–Seed	—	+ Add to CRM
TO Toledo Capital AG GSAKCSHM12 people	88🔒	Zürich	CH	Seed–Late Stage	—	+ Add to CRM
TE tecnet equity NÖ Technologiebeteiligungs-Invest GmbH JMRDPBDA8 people	88🔒	St. Pölten	AT	Seed–Series A	$324K – $3.2M	+ Add to CRM
WA WakeUp Capital MPAPMWJC8 people	88🔒	Dublin	IE	Pre-Seed–Seed	—	+ Add to CRM
DB DBH Investment Zrt. DSDLDFDJ9 people	88🔒	Budapest	HU	Seed–Series B	$216K – $1.6M	+ Add to CRM
OP Open Circle Capital AMJKRRRT7 people · Leads rounds	88🔒	Vilnius	LT	Seed–Series A	$108K – $540K	+ Add to CRM
TR TRANGELS ETOE2 people	88🔒	Istanbul	TR	Pre-Seed–Seed	—	+ Add to CRM
SE Selvedge Venture ATRTEBKS4 people	88🔒	London	GB	Pre-Seed–Series A	—	+ Add to CRM

InHealth Ventures

LondonPre-Seed–Series A$500K – $3M

IBBELBRB5 people

Rosetta Capital Ltd.

OxfordGrowth–Late Stage

JHKMMFDL8 people

SyndicateRoom

CambridgePre-Seed–Series A

TBMGMGAP5 people

Criteria Bio Ventures

BarcelonaSeed–Series B

PCACSCSC7 people

Qubit Health Capital

London

JNPRDDDM10 people

Sentica Partners Oy

HelsinkiGrowth$1.1M – $10.8M

JWMUPTRL10 people

Empirical Ventures

LondonPre-Seed–Seed

DBBMDJHT5 people

Vespucci Partners

BudapestSeed–Series A$648K – $4.9M

ARDBLZJS5 people

Granatus Ventures

YerevanSeed

MHPHYSLD4 people

Simpact Ventures

WarszawaPre-Seed–Series A$500K – $2M

JOKGWMKP6 people

Vesalius Biocapital Partners

LuxembourgSeed–Growth$11M

APCSGMGG6 people

Avonmore Developments

LondonPre-Seed–Seed$63K – $315K

MBSB2 people

Linden Capital

ChicagoPre-Seed–Series A

ABBC2 people

Future Positive Capital

Pre-Seed–Series A

SHATESPR4 people

Montis Capital

WarsawSeries A–Growth$1.6M – $5.5M

ŁDTPMGWS4 people

Target Partners

MunichSeed–Late Stage$1.1M – $3.2M

BVDTJWMK7 people

Startup Funding Club

Pre-Seed–Seed

JZRSSG3 people

Toledo Capital AG

ZürichSeed–Late Stage

GSAKCSHM12 people

tecnet equity NÖ Technologiebeteiligungs-Invest GmbH

St. PöltenSeed–Series A$324K – $3.2M

JMRDPBDA8 people

WakeUp Capital

DublinPre-Seed–Seed

MPAPMWJC8 people

DBH Investment Zrt.

BudapestSeed–Series B$216K – $1.6M

DSDLDFDJ9 people

Open Circle Capital

VilniusSeed–Series A$108K – $540K

AMJKRRRT7 people

TRANGELS

IstanbulPre-Seed–Seed

ETOE2 people

Selvedge Venture

LondonPre-Seed–Series A

ATRTEBKS4 people

Data sourced from public filings and firms' own websites — see our methodology.